Synopsis:
Anondita Medicare Ltd secured a significant contract as the Lowest Bidder for supplying family planning products under the government program.
The healthcare segment witnessed investor interest following the news of a government contract award for family planning products, reflecting potential revenue growth and strong public health collaboration.
Anondita Medicare Ltd, with a market capitalization of Rs. 660.16 crore, opened at Rs. 365, hitting a high of Rs. 383.40 against a previous close of Rs. 351.20, marking an intraday increase of 9.16 percent.
What’s the News?
Anondita Medicare Ltd was awarded the contract as the Lowest Bidder (L1) for various family planning products, including condoms, oral contraceptive pills, emergency contraceptive pills, pregnancy test kits, injectable contraceptives, and intrauterine contraceptive devices (IUCDs).
The total quantity to be supplied under the two-packet bid amounts to 257 million units, with the primary focus on free-supply condoms for the family planning program. Detailed allocations include 198 million condoms, 30.5 million oral contraceptive pills, 4.6 million emergency contraceptive pills, 15 million pregnancy test kits, 4 million injectable contraceptives, and 952.2 thousand tubal rings. The total value of the contract is Rs. 36.37 crore.
Financial Snapshot
As of March 31, 2025, Anondita Medicare Ltd reported sales of Rs. 77 crore and expenses of Rs. 51 crore, resulting in an operating profit of Rs. 26 crore. Profit before tax stood at Rs. 22 crore, while net profit was Rs. 16 crore.
The balance sheet shows reserves of Rs. 25 crore and borrowings of Rs. 27 crore, with other liabilities amounting to Rs. 13 crore. Fixed assets are valued at Rs. 14 crore, other assets at Rs. 55 crore, and investments at Rs. 3 crore. The stock trades at a PE of 41.7 compared with the industry PE of 53.6.
Also read: Bulk Deal: 3 Stocks in which FIIs and DIIs change hands worth up to ₹50 Cr
About the Company
Founded in March 2024, Anondita Medicare Limited is a manufacturer of flavored male condoms, with its flagship product branded as “COBRA.” The company produces 562 million condoms annually and operates a manufacturing facility in Noida, Uttar Pradesh.
Anondita Medicare exports to Southeast Asia, Africa, and the Middle East and works closely with global health organizations, NGOs, and governments to support family planning and public health initiatives. Its distribution network ensures timely delivery through wholesalers, retailers, e-commerce platforms, and government health programs.
Written by – Manan Gangwar
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
